课题基金 / 基金详情

IN VIVO AND INTRACELLULAR ROLES OF LEUKOTRIENE B4 RECEPTOR.

IN VIVO AND INTRACELLULAR ROLES OF LEUKOTRIENE B4 RECEPTOR.
白三烯 B4 受体的体内和细胞内作用。
批准号:
11670111
负责人:
YOKOMIZO Takehiko
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

YOKOMIZO Takehiko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To investigate the biological functions of leukotriene B4 receptor in vivo, we established a line of mice deficient in high-affinity leukotriene B4 receptor (BLT1). Embryonic stem (ES) cells were transfected with a targeting vector for BLT1, and several clones were isolated and confirmed for their homologous recombination by Southern blotting. These ES cells were microinjected to blastcysts, transferred to pseudopregnant female mice, and subsequently chimeric mice were obtained. These chimeric mice are crossed among them, and finally BLT1-deficient mice were born. Now these mice are under backcrossing to examine their phenotype.CHO cells stably expressing BLT1 showed robust chemotaxis toward LTB4 in vitro, so we tried to examine the chemotactic activities of these cells in vivo. Rat acute ischemic-reperfusion renal injury was initiated by 45 minute-clamping of the renal artery. After 24 hrs, cells were injected into the injured kidney, and were allowed to chemotax for 4 hrs. Only in ca … More se of ischemic kidney, not in the sham-operated kdney, CHO cells expressing BLT1 migrated into the peritubal portion of the kidney. Control cells transfected with empty vector did not migrate at all. Prefeeding of the rats with BLT antagonist (Ono 4057) not only inhibited the cells migration, but also reduced the severity of the renal failure, suggesting that LTB4-BLT1 interaction plays important roles in the initiation and the progression of ischemic renal failure.(Noiri, E., et al Proc.Natl.Acad.Sci.U.S.A., 2000)To clarify the molecular mechanisms of the cell-specific expression of BLT1, we examined the transcriptional regulation of BLT1. BLT1 gene is a small gene within 4 kbps, and its promoter contains no TATA-box, but an Initiator sequence. Serial deletion analyses revealed that Sp-1 at-50 from the initiation site plays a pivotal role in BLT1 transcription. Moreover, the promoter region was totally methylated in BLT1-nonexpressing cells, but not in the expressing cells. In vitro methylation of BLT1 promoter almost completely inhibited its promoter activity.(Kato, K., et al.J.Exp.Med.2000)On the course of analyzing BLT1 promoter, we found a novel gene with structural similarities with BLT1. The encoded protein was a novel G-protein-coupled receptor, and exhibited a low-affinity, but significant binding to LTB4. This receptor efficiently transduces intracellular signaling toward calcium increase, inhibition of ademylyl cyclase, and chemotaxis by application of LTB4, thus we named it a second LTB4 receptor, BLT2.(Yokomizo, et al.J.Exp.Med.2000, Yokomizo, T.et al.J.Biol.Chem.2001) Less
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
Toda,A. 他: "Cloning and characterization of rat leukotriene B4 receptor."Biochem.Biophys.Res.Commun.. 262. 806-812 (1999)
Toda, A. 等人:“大鼠白三烯 B4 受体的克隆和表征。”Biochem.Biophys.Res.Commun. 262. 806-812 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Okamoto,H. 他: "Inhibitory regulation of Rac activation, membrane ruffling and cell migration by sphingosine-1-phosphate receptor Edg5,but not Edg1 or Edg3."Mol.Cell Biol.. 20. 9247-9261 (2001)
Okamoto, H. 等人:“1-磷酸鞘氨醇受体 Edg5 对 Rac 激活、膜皱褶和细胞迁移的抑制调节,但 Edg1 或 Edg3 则不然。”Mol.Cell Biol.. 20. 9247-9261 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yokomizo, T., Izumi, T., and Shimizu, T.: "Leukotriene B4 : metabolism and signal transduction."Arch.Biochem.Biophys.. 385. 231-241 (2001)
Yokomizo, T.、Izumi, T. 和 Shimizu, T.:“白三烯 B4:代谢和信号转导。”Arch.Biochem.Biophys.. 385. 231-241 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yokomizo,T 他: "A Second Leukotriene B4 Receptor, BLT2.A new therapeutic target in inflammation and immunological disorders."J.Exp.Med.. 192. 421-432 (2000)
Yokomizo, T 等人:“第二个白三烯 B4 受体,BLT2。炎症和免疫性疾病的新治疗靶点。”J.Exp.Med.. 192. 421-432 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
32
    Identification of GPCR binding proteins by using a novel anti-FLAG antibody and magnetic nanobeads
    Roles of receptors for lipid mediators in inflammation and immunity
    • 批准号:
      21390083
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.81万
    • 财政年份:
      2009
    • 负责人:
      YOKOMIZO Takehiko
    • 依托单位:
    Roles of lipid mediators and receptors in inflammation and immuni
    • 批准号:
      18390096
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.91万
    • 财政年份:
      2006
    • 负责人:
      YOKOMIZO Takehiko
    • 依托单位:
    Roles of G-protein coupled receptors in inflammation and immunity.
    • 批准号:
      16390090
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.02万
    • 财政年份:
      2004
    • 负责人:
      YOKOMIZO Takehiko
    • 依托单位:
    国内基金
    海外基金
    木瓜总三萜靶向BLT1/STAT3轴调控免疫细胞 治疗酒精性肝损伤的机制研究
    • 批准号:
      JCZRLH202601138
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    LTB4/BLT1轴调控NLRP3炎症小体对糖尿病认知功能障碍的作用研究
    • 批准号:
      82371213
    • 项目类别:
      面上项目
    • 资助金额:
      47.00万元
    • 批准年份:
      2023
    • 负责人:
      王修哲
    • 依托单位:
    SOCS1/LTB4/BLT1通路在慢性阻塞性肺疾病早期炎症启动作用的研究
    • 批准号:
      81570029
    • 项目类别:
      面上项目
    • 资助金额:
      55.0万元
    • 批准年份:
      2015
    • 负责人:
      周敏
    • 依托单位:
    LTB4/BLT1轴调控肌成纤维细胞形成参与系统性硬化症发病的作用与机制
    • 批准号:
      81501391
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      18.0万元
    • 批准年份:
      2015
    • 负责人:
      梁敏锐
    • 依托单位: